titlesubmit dateissue date
Now showing items 1-20 of 32
A cluster-randomised clinical trial comparing two cardiovascular health education strategies in a child population: the Savinghearts project
Abandono del tratamiento antituberculoso en la población inmigrante: la movilidad y la falta de apoyo familiar
Artesunate/amodiaquine malaria treatment for Equatorial Guinea (Central Africa)
Change and predictors of quality of life in institutionalized older adults with dementia
Characteristics and outcomes of medically managed patients with non-ST-segment elevation acute coronary syndromes: Insights from the multinational EPICOR Asia study.
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.
Disability transitions after 30 months in three community-dwelling diagnostic groups in Spain
European mitochondrial haplogroups are associated with CD4+ T cell recovery in HIV-infected patients on combination antiretroviral therapy.
Extended dual antiplatelet therapy after acute coronary syndrome in Spain: Results from the EPICOR study.
Gender differences in health related quality of life of young heroin users
Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy
Hepatitis B virus infection and development of chronic kidney disease: a cohort study.
High-risk occupations for breast cancer in the Swedish female working population
HIV-1 Dual Infected LTNP-EC Patients Developed an Unexpected Antibody Cross-Neutralizing Activity
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome.
Impact of Frailty and Disability on 30-Day Mortality in Older Patients With Acute Heart Failure.
Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.
Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD
Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome
Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies